Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (181)	1/9/2003 10:50:23 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ABMD Started on an up-gap today.<g> The FDA has approved its advanced heart assist device and the company is seeking to commercialize its AbioCor Implantable Replacement Heart and the Penn State Heart, two heart replacement systems that are under development. Yesterday it announced that an AbioCor implant was performed Tuesday by University of Louisville surgeons at Jewish Hospital in Louisville, KY. siliconinvestor.com The stock is now trading above its Jan.6 H but it still needs to close above its Dec.13 H of 4.87 before it can test its Nov.29 H at 5.46 siliconinvestor.com The stock has been selling close to book value. The insiders hold around 35% and there is a 14% short position. The R/R at present levels appears to be favorable. siliconinvestor.com Bernard